Gevo (GEVO) 10-Q 9 May 22 2022 Q1 Quarterly report Financial data

Cover page

Cover page - shares	3 Months Ended
	Mar. 31, 2022	May 06, 2022
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2022
Document Transition Report	false
Entity File Number	001-35073
Entity Registrant Name	GEVO, INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	87-0747704
Entity Address, Address Line One	345 Inverness Drive South
Entity Address, Address Line Two	Building C, Suite 310
Entity Address, City or Town	Englewood
Entity Address, State or Province	CO
Entity Address, Postal Zip Code	80112
City Area Code	303
Local Phone Number	858-8358
Title of 12(b) Security	Common Stock, par value $0.01 per share
Trading Symbol	GEVO
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		201,752,722
Entity Central Index Key	0001392380
Current Fiscal Year End Date	--12-31
Amendment Flag	false
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q1
Entity Filer Category	Large Accelerated Filer

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Current assets
Cash and cash equivalents	$ 44,626	$ 40,833
Marketable securities (current)	265,813	275,340
Restricted cash (current)	16,216	25,032
Accounts receivable, net	168	978
Inventories	2,735	2,751
Prepaid expenses and other current assets	5,861	6,857
Total current assets	335,419	351,791
Property, plant and equipment, net	156,896	139,141
Long-term marketable securities	32,724	64,396
Long-term restricted cash	70,238	70,168
Operating right-of-use assets	2,209	2,414
Finance right-of-use assets	26,887	27,297
Intangible assets, net	8,656	8,938
Deposits and other assets	5,631	2,331
Total assets	638,660	666,476
Current liabilities
Accounts payable and accrued liabilities	13,410	28,288
Operating lease liabilities (current)	416	772
Finance lease liabilities (current)	4,029	3,413
Loans payable - other (current)	89	158
Total current liabilities	17,944	32,631
2021 Bonds payable (long-term)	66,669	66,486
Loans payable - other (long-term)	276	318
Operating lease liabilities (long-term)	1,838	1,902
Finance lease liabilities (long-term)	17,403	17,797
Other long-term liabilities	95	87
Total liabilities	104,225	119,221
Stockholders' Equity
Common stock, $0.01 par value per share; 500,000,000 and 250,000,000 shares authorized at March 31, 2022 and December 31, 2021, respectively; 201,752,722 and 201,988,662 shares issued and outstanding at March 31, 2022 and December 31, 2021, respectively.	2,019	2,020
Additional paid-in capital	1,107,051	1,103,224
Accumulated other comprehensive loss	(1,587)	(614)
Accumulated deficit	(573,048)	(557,375)
Total stockholders' equity	534,435	547,255
Total liabilities and stockholders' equity	$ 638,660	$ 666,476
Common stock, shares authorized (in shares)	500,000,000	250,000,000

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Other revenue	$ 0	$ 80
Total revenues	232	93
Cost of production (including non-cash compensation expense of $0.09 million and nil, respectively)	3,090	901
Depreciation and amortization	1,091	1,093
Total cost of goods sold	4,181	1,994
Gross loss	(3,949)	(1,901)
Operating expenses
Research and development expense (including non-cash compensation expense of $0.1 million and $0.5 million, respectively)	1,192	1,378
Selling, general and administrative expense (including non-cash compensation expense of $1.4 million and $0.5 million, respectively)	9,367	3,814
Preliminary stage project costs	507	2,727
Other operations (including non-cash compensation expense of $0.1 million and nil, respectively)	589	0
Depreciation and amortization	351	58
Total operating expenses	12,006	7,977
Loss from operations	(15,955)	(9,878)
Other income (expense)
(Loss) gain from change in fair value of derivative warrant liability	0	(53)
Interest expense	(2)	(5)
Interest and dividend income	252	31
Other income (expense), net	32	(152)
Total other income (expense), net	282	(179)
Net loss	$ (15,673)	$ (10,057)
Net loss per share - basic (in dollars per share)	$ (0.08)	$ (0.05)
Net loss per share - diluted (in dollars per share)	$ (0.08)	$ (0.05)
Weighted-average number of common shares outstanding - basic (in shares)	201,925,747	183,566,524
Weighted-average number of common shares outstanding - diluted (in shares)	201,925,747	183,566,524
Ethanol sales and related products, net
Revenue from contract with customer	$ 169	$ 0
Hydrocarbon revenue
Revenue from contract with customer	$ 63	$ 13

CONSOLIDATED STATEMENTS OF COMP

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Statement of Comprehensive Income [Abstract]
Net loss	$ (15,673)	$ (10,057)
Unrealized gain (loss) on available-for-sale securities, net of tax	(974)	0
Adjustment for net gain (loss) realized and included in net income, net of tax	1	0
Total change in other comprehensive income (loss)	(973)	0
Comprehensive loss	$ (16,646)	$ (10,057)

CONSOLIDATED STATEMENTS OF STOC

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($) $ in Thousands	Total	Common Stock	Paid-In Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2020		128,138,311
Beginning balance at Dec. 31, 2020	$ 146,379	$ 1,282	$ 643,269	$ 0	$ (498,172)
Common stock Issued upon exercise of warrants (in shares)		1,863,058
Issuance of common stock upon exercise of warrants	1,117	$ 18	1,099
Non-cash stock-based compensation	562		562
Issuance of common stock under stock plans, net of taxes ( in shares)		(121,499)
Issuance of common stock under stock plans, net of taxes		$ (1)	1
Other comprehensive loss	0
Net loss	(10,057)				(10,057)
Issuance of common stock, net of issuance costs (in shares)		68,170,579
Issuance of common stock, net of issuance costs	457,690	$ 682	457,008
Ending balance (in shares) at Mar. 31, 2021		198,050,449
Ending balance at Mar. 31, 2021	595,691	$ 1,981	1,101,939	0	(508,229)
Beginning balance (in shares) at Dec. 31, 2021		201,988,662
Beginning balance at Dec. 31, 2021	547,255	$ 2,020	1,103,224	(614)	(557,375)
Common stock Issued upon exercise of warrants (in shares)		4,677
Issuance of common stock upon exercise of warrants	3		3
Non-cash stock-based compensation	4,044		4,044
Issuance of common stock under stock plans, net of taxes ( in shares)		(240,617)
Issuance of common stock under stock plans, net of taxes	(221)	$ (1)	(220)
Other comprehensive loss	(973)			(973)
Net loss	(15,673)				(15,673)
Ending balance (in shares) at Mar. 31, 2022		201,752,722
Ending balance at Mar. 31, 2022	$ 534,435	$ 2,019	$ 1,107,051	$ (1,587)	$ (573,048)

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Operating Activities
Net loss	$ (15,673)	$ (10,057)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation	4,258	925
Depreciation and amortization	1,442	1,149
Non-cash lease expense	139	17
Non-cash interest expense	1,150	0
Changes in operating assets and liabilities:
Accounts receivable	810	435
Inventories	16	39
Prepaid expenses and other current assets, deposits and other assets	(2,317)	(4,273)
Accounts payable, accrued expenses and long-term liabilities	(2,285)	4,600
Net cash used in operating activities	(12,460)	(7,165)
Investing Activities
Acquisitions of property, plant and equipment	(31,218)	(4,630)
Acquisition of patent portfolio	(10)	0
Proceeds from sale and maturity of marketable securities	71,082	0
Purchase of marketable securities	(31,993)	0
Net cash used in investing activities	7,861	(4,630)
Financing Activities
Debt and equity offering costs	0	(31,683)
Proceeds from issuance of common stock and common stock warrants	0	489,373
Proceeds from exercise of warrants	3	1,117
Net settlement of common stock under stock plans	(220)	0
Payment of loans payable - other	(103)	(27)
Payment of finance lease liabilities	(34)	0
Net cash provided by financing activities	(354)	458,780
Net increase (decrease) in cash and cash equivalents	(4,953)	446,985
Cash, cash equivalents and restricted cash at beginning of period	136,033	78,338
Cash, cash equivalents and restricted cash at end of period	131,080	525,323
Schedule of cash, cash equivalents and restricted cash
Cash and cash equivalents	44,626	525,323
Restricted cash (current)	16,216	0
Long-term restricted cash	70,238	0
Total cash, cash equivalents and restricted cash	131,080	525,323
Supplemental disclosures of cash and non-cash investing and financing transactions
Cash paid for interest	2	3
Cash paid for interest capitalized to construction in progress	516	0
Non-cash interest capitalized to construction in progress	1	0
Non-cash purchase of property, plant and equipment	7,530	999
Right-of-use asset purchased with operating lease	$ 0	$ 1,562

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parentheticals) - $ / shares	Mar. 31, 2022	Dec. 31, 2021
Statement of Financial Position [Abstract]
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	500,000,000	250,000,000
Common stock shares issued (in shares)	201,752,722	201,988,662
Common stock, shares outstanding (in shares)	201,752,722	201,988,662

CONSOLIDATED STATEMENTS OF OP_2

CONSOLIDATED STATEMENTS OF OPERATIONS (Parentheticals) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Stock-based compensation	$ 4,258	$ 925
Cost of production
Stock-based compensation	90	0
Research and development
Stock-based compensation	100	500
Selling, general and administrative
Stock-based compensation	1,400	500
Other
Stock-based compensation	$ 100	$ 0

Deposits and Other Assets

Deposits and Other Assets	3 Months Ended
	Mar. 31, 2022
Other Assets, Noncurrent [Abstract]
Deposits and Other Assets	Deposits and Other Assets Deposits and other assets include the following: March 31, 2022 December 31, 2021 Deposits (1) $ 881 $ 831 Investment in Juhl (2) 1,500 1,500 Exclusivity fees (3) 3,250 — Total Deposits and Other Assets $ 5,631 $ 2,331 (1) Deposits for legal services and for product for Net-Zero 1. (2) Investment in Juhl's future wind farms.

Nature of Business, Financial C

Nature of Business, Financial Condition and Basis of Presentation	3 Months Ended
	Mar. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Nature of Business, Financial Condition and Basis of Presentation	Nature of Business, Financial Condition and Basis of Presentation Nature of business. Gevo, Inc. (Nasdaq: GEVO) ("Gevo" or the "Company," which, unless otherwise indicated, refers to Gevo, Inc. and its subsidiaries), a Delaware corporation founded in 2005, is a growth-oriented company with the mission of solving greenhouse gas emissions for those sectors of the transportation industry that are not amenable to electrification or hydrogen. The Company is focused on transforming renewable energy into energy-dense liquid hydrocarbons that can be used as renewable fuels, such as sustainable aviation fuel ("SAF"), with the potential to achieve a “net-zero” greenhouse gas ("GHG") footprint. The Company uses the Argonne National Laboratory’s GREET (Greenhouse gases, Regulated Emissions, and Energy use in Transportation) model (the "GREET Model") to measure, predict and verify GHG emissions across the life-cycle of its products. The “net-zero” concept means Gevo expects that by using renewable and substantially decarbonized energy sources, drop-in hydrocarbon fuels can be produced that have a net-zero, full life cycle footprint measured from the capture of renewable carbon through the burning of the fuel. Gevo's primary market focus, given current demand and growing customer interest, is SAF. The Company believes it also has commercial opportunities for other renewable hydrocarbon products, such as (i) hydrocarbons for gasoline blendstocks and diesel fuel, (ii) ingredients for the chemical industry, such as ethylene and butenes, and (iii) plastics, materials and other chemicals. The Company believes it has the technology and know-how to convert various carbohydrate feeds through a fermentation process into alcohols and then transform the alcohols into renewable fuels and materials. While the Company expects its first major capital deployments to focus on the production of SAF, Gevo recognizes that there are opportunities to operate in several different markets, and it will pursue those opportunities when appropriate based on customer interest, access to capital and expected investment returns. Gevo currently operates a wholly-owned development plant in Luverne, Minnesota (the "Luverne Facility"). The Luverne Facility was originally constructed in 1998 and is located on approximately 55 acres of land, which contains approximately 50,000 square feet of building space. Our Luverne Facility is a scale up and development site. Gevo intends to use the Luverne Facility to prove our processes, process concepts, unit operations and for other purposes in order to optimize feedstocks and the processes used for producing hydrocarbons from alcohols. Gevo's renewable natural gas ("RNG") project ("NW Iowa RNG") owned by Gevo NW Iowa RNG, LLC, will generate RNG captured from dairy cow manure supplied by three dairies located in Northwest Iowa totaling over 20,000 milking cows. Animal manure can be digested anaerobically to produce biogas, which is then upgraded to pipeline quality gas referred to as RNG. Gevo NW Iowa RNG, LLC intends to sell RNG to the California market through an agreement with BP Canada Energy Marketing Corp. and BP Products North America Inc. (collectively, "BP"). Our dairy farm partners realize a variety of benefits including improved operational and environmental compliance options. These services facilitate long-term relationships with project hosts that may serve as a source for future projects and relationships. Gevo believes that RNG has potential to displace fossil-based natural gas used in the future production of net-zero hydrocarbon manufacturing facilities, providing the benefit of lowering the carbon intensity of hydrocarbon fuels. In 2021, we began construction on NW Iowa RNG under a self-perform project delivery format. We completed most of the construction efforts at the end of 2021, and in January 2022, we began the process of commissioning the project. NW Iowa RNG is expected to be completed within budget. All digesters are currently in the start-up phase and are expected to reach steady production levels in the second quarter of 2022. When fully operational, NW Iowa RNG is expected to generate approximately 355,000 MMBtu of RNG per year. We also operate a demonstration facility in Silsbee, Texas in partnership with South Hampton Resources, Inc. (the "South Hampton Facility"), from which the Company produces limited volumes of SAF and liquid hydrocarbon fuel. Ultimately, the Company believes that the attainment of profitable operations is dependent upon future events, including, but not limited to (i) the successful development of the Company's initial Net-Zero Project (the "Net-Zero 1 Project") and future projects for the production of energy dense liquid hydrocarbons using renewable energy and our proprietary technology; and (ii) the achievement of a level of revenues adequate to support its cost structure. Basis of presentation. The unaudited consolidated financial statements of the Company (which include the accounts of its wholly-owned subsidiaries Gevo Asset, LLC, Gevo RNG HoldCo, LLC, Gevo NW Iowa RNG, LLC, Gevo Net-Zero HoldCo, LLC, Gevo Net-Zero 1 , LLC, and Agri-Energy, LLC (“Agri-Energy”)) have been prepared, without audit, pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”). Accordingly, they do not include all information and footnotes required by accounting principles generally accepted in the United States (“GAAP”) for complete financial statements. These statements reflect all normal and recurring adjustments which, in the opinion of management, are necessary to present fairly the financial position, results of operations and cash flows of the Company as of, and for the three months ended, March 31, 2022, and are not necessarily indicative of the results to be expected for the full year. These statements should be read in conjunction with the Company’s audited consolidated financial statements and notes thereto included under the heading “Financial Statements and Supplementary Data” in Part II, Item 8 of the Company’s Annual Report on Form 10-K for the year ended December 31, 2021 . The financial statements at December 31, 2021, have been derived from the audited financial statements as of that date. For further information, refer to our audited financial statements and notes thereto included for the year ended December 31, 2021 (the "2021 Annual Report"). Reclassifications. The Company reclassified certain prior period amounts to conform to the current period presentation, including the categorization of depreciation and amortization on the Consolidated Statements of Operations. These reclassifications had no impact on total revenues, total cost of goods sold, total operating expenses, net loss or stockholders' equity for any period.

Revenues from Contracts with Cu

Revenues from Contracts with Customers and Other Revenues	3 Months Ended
	Mar. 31, 2022
Revenue from Contract with Customer [Abstract]
Revenues from Contracts with Customers and Other Revenues	Revenues from Contracts with Customers and Other Revenues The Company's limited revenues are derived from two development-scale plants: (i) the South Hampton Facility and (ii) the Luverne Facility. These revenues are from customer contracts for ethanol sales and related products and hydrocarbon revenues, which include SAF, isooctene, and isooctane. These are sold mostly on a free-on-board, shipping point basis (recognized at a point in time), are independent transactions, do not provide post-sale support or promises to deliver future goods, and are single performance obligations. Historically, grant revenues consisted of governmental and cooperative research grants, while other revenue includes consulting services and short-term leases for certain storage facilities at the Luverne Facility. For the quarters ended March 31, 2022 and 2021, there were no variable revenues and as of March 31, 2022 and December 31, 2021, there were no remaining unfulfilled or partially fulfilled performance obligations. The Company does not offer explicit or implicit price concessions, so it records the revenue and trade receivables at 100% of the transaction price. Since all amounts are provided and due in less than one year, the Company elects to not record a financing component.

Net loss Per Share

Net loss Per Share	3 Months Ended
	Mar. 31, 2022
Earnings Per Share [Abstract]
Net loss Per Share	Net loss Per Share Basic net loss per share is calculated based on the weighted average number of common shares outstanding for the period. Diluted net loss per share is calculated based on the assumption that stock options and other dilutive securities outstanding, which have an exercise price less than the average market price of the Company's common shares during the period, would have been exercised on the later of the beginning of the period or the date granted and that the funds obtained from the exercise were used to purchase common shares at the average market price during the period. None of the Company's stock options or other dilutive securities are considered to be dilutive in periods with net losses. The effect of the Company’s dilutive securities is calculated using the treasury stock method and only those instruments that result in a reduction in net income per common share are included in the calculation. Diluted net loss per share for the three months ended March 31, 2022 and 2021 excluded 1,751,170 and 220,099, respectively, of common stock equivalents because the effect of their inclusion would be anti-dilutive or would decrease the reported net loss per share. Basic and diluted net loss per share is calculated as follows (net loss in thousands): Three Months Ended March 31, 2022 2021 Net loss $ (15,673) $ (10,057) Basic and diluted weighted-average shares outstanding 201,925,747 183,566,524 Basic and diluted net loss per share $ (0.08) $ (0.05)

Prepaid and Other Current Asset

Prepaid and Other Current Assets	3 Months Ended
	Mar. 31, 2022
Prepaid Expense and Other Assets, Current [Abstract]
Prepaid and Other Current Assets	Prepaid and Other Current Assets The following table sets forth the components of the Company’s prepaid and other current assets (in thousands): March 31, 2022 December 31, 2021 Prepaid insurance $ 397 $ 805 Interest receivable 1,252 1,530 Exclusivity fees — 3,250 Prepaid engineering 2,275 409 Prepaid other 1,937 863 Total Prepaid and other current assets $ 5,861 $ 6,857 The $3.3 million of prepaid fees above are exclusivity fees and are reported in Deposits and other assets in the Consolidated Balance Sheets (Note 13) as of March 31, 2022.

Marketable Securities

Marketable Securities	3 Months Ended
	Mar. 31, 2022
Investments, Debt and Equity Securities [Abstract]
Marketable Securities	Marketable Securities The Company's investments in marketable securities are stated at fair value and are available-for-sale. The following table summarizes the Company's investments in marketable securities (in thousands): Available-for-Sale Securities at Maturity Amortized Cost Basis Gross Unrealized Losses Fair Value Short-term marketable securities U.S. Treasury notes Within one year $ 188,665 $ (527) $ 188,138 U.S. Government-sponsored enterprise securities Within one year 78,375 (700) 77,675 Total short-term marketable securities $ 267,040 $ (1,227) $ 265,813 Long-term marketable securities U.S Treasury notes Within two years $ 11,040 $ (72) $ 10,968 U.S. Government-sponsored enterprise securities Within two years 22,044 (288) 21,756 Total long-term marketable securities $ 33,084 $ (360) $ 32,724 Available-for-Sale Securities at Maturity Amortized Cost Basis Gross Unrealized Losses Fair Value Short-term marketable securities U.S. Treasury notes Within one year $ 226,136 $ (344) $ 225,792 U.S. Government-sponsored enterprise securities Within one year 49,618 (70) 49,548 Total short-term marketable securities $ 275,754 $ (414) $ 275,340 Long-term marketable securities U.S Treasury notes Within two years $ — $ — $ — U.S. Government-sponsored enterprise securities Within two years 64,596 (200) 64,396 Total long-term marketable securities $ 64,596 $ (200) $ 64,396 The cost of securities sold is based upon the specific identification method. Interest receivable related to the marketable securities of $1.3 million was included within prepaid expenses and other current assets on the accompanying Consolidated Balance Sheets as of March 31, 2022. Interest income totaled $1.6 million the three months ended March 31, 2022 ( nil for the three months ended March 31, 2021) and is included in "Interest and dividend income" in the Consolidated Statements of Operations. Future maturities of the Company's marketable securities are $207.0 million in 2022 and $91.5 million in 2023.

Leases, Right-of-Use Assets and

Leases, Right-of-Use Assets and Related Liabilities	3 Months Ended
	Mar. 31, 2022
Leases [Abstract]
Leases, Right-of-Use Assets and Related Liabilities	Leases, Right-of-Use Assets and Related Liabilities The Company is party to an operating lease contract for the Company’s office and research facility in Englewood, Colorado, that expires in January 2029. The lease contains an option to extend the lease which management does not reasonably expect to exercise, so it is not included in the length of the term. The Company also has one production line piece of equipment with an operating lease that expires in 2024. As of March 31, 2022, right-of-use assets under operating leases totaling $2.2 million are included in "Operating right-of use assets," and related lease liabilities totaling $2.3 million ($0.4 million in current and $1.8 million in long-term) are included in the Consolidated Balance Sheets. The Company also has four finance leases for land under arrangements related to NW Iowa RNG. Under these contracts, the Company leases land from dairy farmers on which it has built three anaerobic digesters, related equipment and pipelines to condition raw biogas from cow manure provided by the farmers. The partially conditioned biogas will be transported from the three digester sites to a central gas upgrade system located at the fourth site that will upgrade the biogas to pipeline quality RNG for sale. These leases expire at various dates between 2031 and 2050 . Since the Company adopted the practical expedient, all amounts paid to the lessor under these arrangements for cow manure and non-lease services are classified as lease payments and are included in the calculation of the right-of-use assets and lease liabilities. This results in significantly higher right-of-use assets and lease liabilities than if the Company did not elect this practical expedient. The Company also has one office equipment finance lease, which expires in 2025. As of March 31, 2022 , right-of-use assets under finance leases totaling $26.9 million are included in "Finance right-of-use assets," and related lease liabilities totaling $21.4 million ($4.0 million in current and $17.4 million in long-term) are included in the Consolidated Balance Sheets. The following table presents the (a) costs by lease category and (b) other quantitative information relating to the Company’s leases (in thousands): Three Months Ended March 31, 2022 2021 Lease Cost Finance lease cost: Amortization of right-of-use assets (1) $ 464 $ — Interest on lease liabilities (1) 262 11 Operating lease cost 139 61 Short-term lease cost 379 132 Variable lease cost (2) 115 39 Total lease cost $ 1,359 $ 243 (1) $0.6 million and $0.4 million of amortization and interest expense for the three months ended March 31, 2022 and 2021, respectively, were capitalized as part of construction in progress, for related finance lease liabilities of $23.0 million and $0.6 million, respectively. The accumulated capitalized amounts of $3.0 million are included in "Property, plant and equipment, net" in the Consolidated Balance Sheets as the related NW Iowa RNG facilities were still under construction on March 31, 2022. Since these leases include approximately 75% fuel supplies, when the RNG facilities reach 60% production (expected in the second or third quarter of 2022), these capitalized amounts will be moved to inventory, and as units are sold they will be expensed through cost of goods sold. (2) Represents amounts incurred in excess of minimum payments, including payments for common area expenses under our office and research facility lease, and additional amounts due under our NW Iowa RNG leases based on the number of cows maintained by the owners above the minimum required by the contracts of the respective facilities. Three Months Ended March 31, 2022 2021 Other Information Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from finance leases $ 16 $ 6 Operating cash flows from operating leases $ 456 $ 61 Finance cash flows from finance leases $ 34 $ 7 Right-of-use asset obtained in exchange for new finance lease liabilities $ — $ — Right-of-use asset obtained in exchange for new operating lease liabilities $ — $ 1,562 Weighted-average remaining lease term, finance lease (months) 215 221 Weighted-average remaining lease term, operating leases (months) 71 94 Weighted-average discount rate - finance leases (1) 5% 13% Weighted-average discount rate - operating leases (1) 5% 5% (1) The discount rate used for operating and finance leases is based on the Company's implicit borrowing rate ("IBR"). The Company estimated the IBR based on collateralized borrowings for similar terms and payments. The table below shows the future minimum payments under non-cancelable financing and operating leases at March 31, 2022 ( in thousands): Year ending December 31, Operating Leases Finance Leases 2022 (remaining) $ 447 $ 2,204 2023 528 1,713 2024 305 1,729 2025 315 1,743 2026 324 1,781 2027 and thereafter 706 22,130 Total 2,625 31,300 Less: Amounts representing present value discounts 371 9,868 Total lease liabilities 2,254 21,432 Less: current portion 416 4,029 Long-term portion $ 1,838 $ 17,403
Leases, Right-of-Use Assets and Related Liabilities	Leases, Right-of-Use Assets and Related Liabilities The Company is party to an operating lease contract for the Company’s office and research facility in Englewood, Colorado, that expires in January 2029. The lease contains an option to extend the lease which management does not reasonably expect to exercise, so it is not included in the length of the term. The Company also has one production line piece of equipment with an operating lease that expires in 2024. As of March 31, 2022, right-of-use assets under operating leases totaling $2.2 million are included in "Operating right-of use assets," and related lease liabilities totaling $2.3 million ($0.4 million in current and $1.8 million in long-term) are included in the Consolidated Balance Sheets. The Company also has four finance leases for land under arrangements related to NW Iowa RNG. Under these contracts, the Company leases land from dairy farmers on which it has built three anaerobic digesters, related equipment and pipelines to condition raw biogas from cow manure provided by the farmers. The partially conditioned biogas will be transported from the three digester sites to a central gas upgrade system located at the fourth site that will upgrade the biogas to pipeline quality RNG for sale. These leases expire at various dates between 2031 and 2050 . Since the Company adopted the practical expedient, all amounts paid to the lessor under these arrangements for cow manure and non-lease services are classified as lease payments and are included in the calculation of the right-of-use assets and lease liabilities. This results in significantly higher right-of-use assets and lease liabilities than if the Company did not elect this practical expedient. The Company also has one office equipment finance lease, which expires in 2025. As of March 31, 2022 , right-of-use assets under finance leases totaling $26.9 million are included in "Finance right-of-use assets," and related lease liabilities totaling $21.4 million ($4.0 million in current and $17.4 million in long-term) are included in the Consolidated Balance Sheets. The following table presents the (a) costs by lease category and (b) other quantitative information relating to the Company’s leases (in thousands): Three Months Ended March 31, 2022 2021 Lease Cost Finance lease cost: Amortization of right-of-use assets (1) $ 464 $ — Interest on lease liabilities (1) 262 11 Operating lease cost 139 61 Short-term lease cost 379 132 Variable lease cost (2) 115 39 Total lease cost $ 1,359 $ 243 (1) $0.6 million and $0.4 million of amortization and interest expense for the three months ended March 31, 2022 and 2021, respectively, were capitalized as part of construction in progress, for related finance lease liabilities of $23.0 million and $0.6 million, respectively. The accumulated capitalized amounts of $3.0 million are included in "Property, plant and equipment, net" in the Consolidated Balance Sheets as the related NW Iowa RNG facilities were still under construction on March 31, 2022. Since these leases include approximately 75% fuel supplies, when the RNG facilities reach 60% production (expected in the second or third quarter of 2022), these capitalized amounts will be moved to inventory, and as units are sold they will be expensed through cost of goods sold. (2) Represents amounts incurred in excess of minimum payments, including payments for common area expenses under our office and research facility lease, and additional amounts due under our NW Iowa RNG leases based on the number of cows maintained by the owners above the minimum required by the contracts of the respective facilities. Three Months Ended March 31, 2022 2021 Other Information Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from finance leases $ 16 $ 6 Operating cash flows from operating leases $ 456 $ 61 Finance cash flows from finance leases $ 34 $ 7 Right-of-use asset obtained in exchange for new finance lease liabilities $ — $ — Right-of-use asset obtained in exchange for new operating lease liabilities $ — $ 1,562 Weighted-average remaining lease term, finance lease (months) 215 221 Weighted-average remaining lease term, operating leases (months) 71 94 Weighted-average discount rate - finance leases (1) 5% 13% Weighted-average discount rate - operating leases (1) 5% 5% (1) The discount rate used for operating and finance leases is based on the Company's implicit borrowing rate ("IBR"). The Company estimated the IBR based on collateralized borrowings for similar terms and payments. The table below shows the future minimum payments under non-cancelable financing and operating leases at March 31, 2022 ( in thousands): Year ending December 31, Operating Leases Finance Leases 2022 (remaining) $ 447 $ 2,204 2023 528 1,713 2024 305 1,729 2025 315 1,743 2026 324 1,781 2027 and thereafter 706 22,130 Total 2,625 31,300 Less: Amounts representing present value discounts 371 9,868 Total lease liabilities 2,254 21,432 Less: current portion 416 4,029 Long-term portion $ 1,838 $ 17,403

Inventories

Inventories	3 Months Ended
	Mar. 31, 2022
Inventory Disclosure [Abstract]
Inventories	Inventories The following table sets forth the components of the Company’s inventory balances (in thousands): March 31, 2022 December 31, 2021 Raw materials Corn $ 223 $ 301 Enzymes and other inputs 108 183 Nutrients 2 3 Palladium 203 265 Finished goods SAF, Isooctane and Isooctene 501 335 Isobutanol 181 223 Ethanol 82 96 Work in process Agri-Energy 84 83 Gevo 51 — Spare parts 1,300 1,262 Total inventories $ 2,735 $ 2,751 Work in process inventory includes unfinished SAF, isooctane and isooctene inventory. During the three months ended March 31, 2022, the Company adjusted its finished goods and work in process inventory to net realizable value and recorded a $2.9 million loss in cost of goods sold. There were no net realizable losses recorded during the three months ended March 31, 2021, as the Luverne Facility was temporarily shut down due to the COVID-19 pandemic.

Property, Plant, and Equipment

Property, Plant, and Equipment	3 Months Ended
	Mar. 31, 2022
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment	Property, Plant and Equipment The following table sets forth the Company’s property, plant and equipment by classification (in thousands): Useful Life (in years) March 31, 2022 December 31, 2021 Luverne Facility retrofit asset 20 $ 70,820 $ 70,820 Plant machinery and equipment 10 17,949 17,949 Site improvements 10 7,157 7,157 Lab equipment, furniture and fixtures and vehicles 5 6,813 6,811 Demonstration plant 2 3,597 3,597 Buildings 10 2,543 2,543 Leasehold improvements, pilot plant, land and support equipment 2 to 7 2,841 2,802 Computer, office equipment and software 3 to 6 2,338 2,332 Construction in progress — 107,848 88,989 Total property, plant and equipment 221,906 203,000 Less accumulated depreciation and amortization (65,010) (63,859) Property, plant and equipment, net $ 156,896 $ 139,141 The Company recorded depreciation and amortization expense related to property, plant and equipment and intangible assets as follows (in thousands): Three Months Ended March 31, 2022 2021 Depreciation: Cost of goods sold $ 1,086 $ 1,088 Operating expenses 65 56 Patent amortization: Cost of goods sold 5 5 Operating expenses 286 — Total depreciation and amortization $ 1,442 $ 1,149 Construction in progress includes $0.6 million for Gevo, $13.1 million for Agri-Energy, $67.4 million for NW Iowa RNG and $26.8 million for the Net-Zero 1 Project at March 31, 2022. Construction in progress includes $0.4 million for Gevo, $9.1 million for Agri-Energy, $56.9 million for NW Iowa RNG and $22.5 million for Net-Zero 1 Project at December 31, 2021. Construction in progress is not subject to depreciation until the assets are placed into service. Borrowing costs. Borrowing costs directly attributable to acquisition and construction of an asset are capitalized until it is completed and ready for its intended use, and thereafter are recognized in profit or loss for the current period. The Company capitalized $0.5 million and nil of interest expense for the three months ended March 31, 2022, and March 31, 2021, respectively.

Intangible Assets

Intangible Assets	3 Months Ended
	Mar. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets	Intangible AssetsIntangible assets consist of patents, which management evaluates to determine whether they (i) support current products; (ii) support planned research and development, or (iii) prevent others from competing with Gevo's products. The following table sets forth the Company’s identifiable intangible assets by classification (in thousands): March 31, 2022 Gross Carrying Amount Accumulated Amortization Identifiable Intangible Assets, Net Weighted-Average Useful Life (Years) Finite-lived intangible assets: Patents $ 4,580 $ (516) $ 4,064 7.3 Defensive assets 4,900 (308) 4,592 8.4 Identifiable intangible assets $ 9,480 $ (824) $ 8,656 7.9 December 31, 2021 Gross Carrying Amount Accumulated Amortization Identifiable Intangible Assets, Net Weighted-Average Useful Life (Years) Finite-lived intangible assets: Patents $ 4,575 $ (368) $ 4,207 7.3 Defensive assets 4,895 (164) 4,731 8.4 Identifiable intangible assets $ 9,470 $ (532) $ 8,938 7.9 The following table details the estimated amortization of identifiable intangible assets as of March 31, 2022 ( in thousands): Year ending December 31, Patents Defensive Assets Total 2022 (remaining) $ 452 $ 442 $ 894 2023 599 586 1,185 2024 601 588 1,189 2025 599 586 1,185 2026 585 586 1,171 2027 and thereafter 1,228 1,804 3,032 Total $ 4,064 $ 4,592 $ 8,656 See Note 8 for the amortization of intangible assets for the three months ended March 31, 2022 and March 31, 2021

Warrants

Warrants	3 Months Ended
	Mar. 31, 2022
Equity [Abstract]
Warrants	Warrants On February 17, 2022, the Series K warrants expired with 7,126 unexercised warrants. The following table sets forth information pertaining to shares issued upon the exercise of warrants: Issuance Date Expiration Date Exercise Price as of March 31, 2022 Shares Underlying Warrants on Issuance Date Shares Issued upon Warrant Exercises as of March 31, 2022 Shares Underlying Warrants Outstanding as of March 31, 2022 Series 2020-A Warrants (1) 7/6/2020 7/6/2025 $ 0.60 30,000,000 29,914,069 85,931 (1) The Series 2020-A Warrants are equity-classified warrants. During the three months ended March 31, 2022 , common stock was issued as a result of the exercise of warrants as shown below (dollars in thousands): Common Stock Issued Proceeds Series 2020-A Warrants 4,677 $ 3

Accounts Payable and Accrued Li

Accounts Payable and Accrued Liabilities	3 Months Ended
	Mar. 31, 2022
Payables and Accruals [Abstract]
Accounts Payable and Accrued Liabilities	Accounts Payable and Accrued Liabilities The following table sets forth the components of the Company's accounts payable and accrued liabilities (in thousands): March 31, 2022 December 31, 2021 Accounts payable - trade $ 1,399 $ 4,868 NW Iowa RNG accrued project costs 2,902 11,000 Accrued employee compensation 3,294 4,678 Net-Zero 1 accrued project costs 2,778 5,010 Other accrued liabilities 3,037 2,732 Total accounts payable and accrued liabilities $ 13,410 $ 28,288

Debt

Debt	3 Months Ended
	Mar. 31, 2022
Debt Disclosure [Abstract]
Debt	Debt 2021 Bond Issuance On April 15, 2021, on behalf of Gevo NW Iowa RNG, LLC, the Iowa Finance Authority ("the "Authority") issued $68,155,000 of its non-recourse Solid Waste Facility Revenue Bonds (Gevo NW Iowa RNG, LLC Renewable Natural Gas Project), Series 2021 (Green Bonds) (the "2021 Bonds") for NW Iowa RNG. The bond proceeds are being used as a source of construction financing alongside equity from the Company. The bonds were issued under a Trust Indenture dated as of April 1, 2021 (the "Indenture") between the Authority and Citibank, N.A. as trustee (the "Trustee"). The 2021 Bonds mature April 1, 2042. They initially bear interest at 1.50% per annum during the Initial Term Rate Period, (as defined in the Indenture) payable semi-annually on January 1 and July 1 of each year. The bonds are supported by a $71.2 million irrevocable direct pay letter of credit (the "Letter of Credit"), which expires April 4, 2024 (unless terminated earlier), and was issued by Citibank, N.A. The Trustee will draw sufficient amounts on the Letter of Credit to pay the principal and interest until the first mandatory tender date of April 1, 2024. The bonds are callable and re-marketable on or after October 1, 2022. If the bonds have not been called and re-marketed by the first mandatory tender date the Trustee may draw on the Letter of Credit to repay the bonds in their entirety at the purchase price. Gevo deposited $71.2 million with Citibank, N.A. as restricted cash to secure any amounts drawn under the Letter of Credit. As of March 31, 2022, no amounts have been drawn under the Letter of Credit. Gevo anticipates re-marketing the 2021 Bonds in the fall of 2022 under revised terms that will include a long-term maturity date and be non-recourse to Gevo. Upon a successful remarketing, Gevo anticipates that the Letter of Credit, the associated reimbursement agreement and the associated pledge of cash will be terminated, with a concurrent release of the restricted cash securing the Letter of Credit. The 2021 Bonds were issued at a premium of $0.8 million, and debt issuance costs were $3.0 million. The bond debt is classified as long-term debt and is presented net of the premium and issuance costs, which are being amortized over the life of the bonds using the interest method. As of March 31, 2022, the premium balance, and debt issuance cost net of amortization were $0.6 million and $2.1 million, respectively. Restricted cash and cash equivalents . The Company’s restricted cash and restricted cash equivalents consists of unused proceeds from the issuance of the 2021 Bonds, and are restricted for the purpose of constructing NW Iowa RNG projects as well as amounts pledged and assigned to Citibank, N.A. in its capacity as provider of the Letter of Credit as collateral for the reimbursement obligations of Gevo. The proceeds from issuance of the 2021 Bonds are maintained by the Trustee under the Indenture and are released to the Company only to pay costs of the construction of NW Iowa RNG. The Company has used $53.0 million for the project. As of March 31, 2022, unused bond proceeds of $15.2 million are included in restricted cash classified as current since the proceeds will be distributed within 12 months. We expect all construction invoices will be received and paid, and the remaining unused bond proceeds will be released to reimburse Gevo by the end of the second quarter of 2022. As of March 31, 2022 , $71.2 million is held in restricted cash as collateral for the Letter of Credit. The Company is entitled to receive interest income on the restricted cash. The restricted cash held by the Trustee is made up of the following (in thousands). Numbers are stated since inception and as of March 31, 2022: March 31, 2022 Bond proceeds $ 68,995 Disbursement of funds (53,085) Interest paid on bonds (727) Interest income 11 Total restricted cash held by Trustee 15,194 Total restricted cash for collateral 71,260 Total restricted cash and restricted cash equivalents 86,454 Current portion (16,216) Total restricted cash held by Trustee $ 70,238 Loans Payable - Other The equipment loans are secured by the related equipment. In April 2020, the Company and Agri-Energy each entered into a loan agreement with Live Oak Banking Company, pursuant to which the Company and Agri-Energy obtained loans from the Small Business Administration's Paycheck Protection Program (“SBA PPP”) totaling $1.0 million in the aggregate (the "SBA Loans"). On April 15, 2021, the Small Business Administration forgave the entire balance of $0.5 million of the Company's and $0.1 million of Agri-Energy's loans and accrued interest obtained through the SBA PPP. The remaining SBA Loan for Agri-Energy totals $0.3 million, bears interest at 1.0% and matures in April 2025. Monthly payments of $8,230, including interest, began on June 5, 2021, and are payable through April 2025. The summary of the 2021 Bonds and Loans payable - other are as follows (in thousands): Interest Rate Maturity Date March 31, 2022 December 31, 2021 2021 Bonds 1.5% January 2042 $ 66,669 $ 66,486 SBA Loans 1.0% April 2025 296 320 Equipment 4% to 5% February 2022 to December 2024 70 156 Total loans payable - other 67,035 66,962 Less current portion (89) (158) Long-term portion $ 66,946 $ 66,804 Future principal payments for the Company's long-term debt are as follows (in thousands): Year Ending December 31, 2022 (remaining) $ 48 2023 159 2024 66,799 2025 29 2026 — $ 67,035

Stock-Based Compensation

Stock-Based Compensation	3 Months Ended
	Mar. 31, 2022
Equity [Abstract]
Stock-Based Compensation	Stock-Based Compensation Equity incentive plans . In February 2011, the Company’s stockholders approved the Gevo, Inc. 2010 Stock Incentive Plan (as amended and restated to date, the "2010 Plan"), and the Employee Stock Purchase Plan (the "ESPP"). The 2010 Plan provided for the grant of non-qualified stock options, incentive stock options, stock appreciation rights, restricted stock awards, restricted stock units and other equity awards to employees and directors of the Company. On June 9, 2021, with approval of stockholders at the 2021 Annual Meeting of Stockholders, the 2010 Plan was amended and restated, which increased the number of shares of common stock reserved for issuance under the 2010 Plan to a total of 22,980,074. At March 31, 2022, 7,717,026 shares remained available for awards under the 2010 Plan. Restricted common stock and non-qualified stock option activity during the three months ended March 31, 2022, consisted of the following: Period Total Number of Restricted Shares Issued Total Number of Non-qualified Stock Options Granted Vesting Periods Years January 1, 2022 to March 31, 2022 (340,502) (1) — N/A Total (340,502) — (1) Includes shares of common stock cancelled related to the unvested restricted stock awards. ESPP . The offering periods for the ESPP are from January 1 to June 30 and from July 1 to December 31 of each calendar year. The Company has reserved 190 shares of common stock for issuance under the ESPP, of which 190 shares as of March 31, 2022, are available for future issuance. The purchase price of the common stock under the ESPP is 85% of the lower of the fair market value of a share of common stock on the first or last day of the purchase period. There were no purchases of common stock under the ESPP during the three months ended March 31, 2022 or 2021 . Stock-based compensation expense . The Company records stock-based compensation expense during the requisite service period for share-based payment awards granted to employees and non-employees. Our stock-based compensation is classified as either an equity award or a liability award in accordance with generally accepted accounting principles. The fair value of an equity-classified award is determined at the grant date and is amortized on a straight-line basis over the vesting life of the award. The fair-value of a liability-classified award is determined on a quarterly basis through the final vesting date and is amortized based on the current fair value of the award and the percentage of vesting period incurred to date. The following table sets forth the Company’s stock-based compensation expense for the periods indicated (in thousands): Three Months Ended March 31, 2022 2021 Equity Classified Awards Stock options Cost of goods sold $ 85 $ — Research and development 51 — Selling, general and administrative 1,444 — Preliminary stage projects 5 Other 94 Restricted stock Cost of goods sold 108 — Research and development 58 125 Selling, general and administrative 2,050 437 Preliminary stage projects 11 Other 138 Total equity classified awards 4,044 562 Liability Classified Awards Restricted stock Selling, general and administrative 193 — Stock appreciation rights Research and development — 348 Selling, general and administrative 21 15 Total liability classified awards 214 363 Total stock-based compensation $ 4,258 $ 925 Stock option award activity . Stock option activity under the Company’s stock incentive plans and changes during the three months ended March 31, 2022, were as follows: Number of Options Weighted-Average Exercise Price (1) Weighted-Average Remaining Contractual Term (years) Aggregate Intrinsic Value Options outstanding at December 31, 2021 4,739,940 $ 5.14 9.6 $ — Granted — Canceled or forfeited (174,187) $ 5.63 Exercised — Options outstanding at March 31, 2022 4,565,753 $ 5.12 9.4 $ — Options exercisable at March 31, 2022 1,520 $ 427.69 4.4 $ — (1) Exercise price of options outstanding range from $4 to $99,300 as of March 31, 2022 . The higher range is related to historical stock reverse splits. No stock options vested during the three months ended March 31, 2022 . As of March 31, 2022 , the total unrecognized compensation expense, net of estimated forfeitures, relating to stock options was $16.6 million, which is expected to be recognized over the remaining weighted-average period of approximately 3.6 years. Restricted stock . Non-vested restricted stock awards and the changes during the three months ended March 31, 2022, were as follows: Number of Shares Weighted-Average Grant-Date Fair Value Outstanding at December 31, 2021 7,094,785 $ 3.93 Granted — $ — Exercised (165,870) $ 1.09 Canceled or forfeited (174,268) $ 4.53 Vested (364) $ 2.30 Non-vested at March 31, 2022 6,754,283 $ 4.01 The total fair value of restricted stock that vested during the three months ended March 31, 2022, was nil. As of March 31, 2022 , the total unrecognized compensation expense, net of estimated forfeitures, relating to restricted stock awards was $19.4 million, which is expected to be recognized over the remaining weighted-average period of approximately 2.9 years. As of March 31, 2022 , we had recorded a liability of $1.0 million for earned and unvested liability-classified restricted stock awards based on the fair value of our common stock as of March 31, 2022

Income Taxes

Income Taxes	3 Months Ended
	Mar. 31, 2022
Income Tax Disclosure [Abstract]
Income Taxes	Income TaxesThe Company has incurred operating losses since inception, therefore no provision for income taxes was recorded and all related deferred tax assets are fully reserved for. We continue to assess the impact of a deferred tax asset as it relates to income taxes.

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Legal matters . From time to time, the Company has been, and may again become, involved in legal proceedings arising in the ordinary course of its business. The Company is not presently a party to any litigation and is not aware of any pending or threatened litigation against the Company that it believes could have a material adverse effect on its business, operating results, financial condition or cash flows. Indemnifications . In the ordinary course of its business, the Company makes certain indemnities under which it may be required to make payments in relation to certain transactions. As of March 31, 2022 , the Company did not have any liabilities associated with indemnities. In addition, the Company, as permitted under Delaware law and in accordance with its amended and restated certificate of incorporation and second amended and restated bylaws, in each case, as amended to date, indemnifies its officers and directors for certain events or occurrences, subject to certain limits, while the officer or director is or was serving at the Company’s request in such capacity. The duration of these indemnifications, commitments, and guarantees varies and, in certain cases, is indefinite. The maximum amount of potential future indemnification is unlimited; however, the Company has a director and officer insurance policy that may enable it to recover a portion of any future amounts paid. The Company accrues for losses for any known contingent liability, including those that may arise from indemnification provisions, when future payment is probable. No such losses have been recorded to date. Environmental liabilities . The Company’s operations are subject to environmental laws and regulations adopted by various governmental authorities in the jurisdictions in which it operates. These laws require the Company to investigate and remediate the effects of the release or disposal of materials at its locations. Accordingly, the Company has adopted policies, practices and procedures in the areas of pollution control, occupational health and the production, handling, storage and use of hazardous materials to prevent material environmental or other damage, and to limit the financial liability which could result from such events. Environmental liabilities are recorded when the Company’s liability is probable, and the costs can be reasonably estimated. No environmental liabilities have been recorded as of March 31, 2022. In February 2022, an incident occurred at one of the anaerobic digesters that is part of NW Iowa RNG that resulted in the accidental discharge of a mixture of water and manure into the environment. We promptly notified the Iowa Department of Natural Resources (the "DNR") and began mitigation work to minimize the impact of the discharge. The DNR has issued a notice of violation in connection with the discharge. In April 2022, two separate incidents occurred at two of the anaerobic digesters that are part of NW Iowa RNG that resulted in the accidental discharge of very small amounts of water and manure into the environment. The DNR has issued notices of violation in connection with the two discharges. There is a possibility that the DNR will initiate an enforcement action with respect to the discharges described above that could result in a monetary sanction being levied against Gevo for the accidental discharges. We do not believe that any such monetary sanctions would be material to the Company.

Fair Value Measurements

Fair Value Measurements	3 Months Ended
	Mar. 31, 2022
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements Accounting standards define fair value, outline a framework for measuring fair value, and detail the required disclosures about fair value measurements. Under these standards, fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date in the principal or most advantageous market. Standards establish a hierarchy in determining the fair market value of an asset or liability. The fair value hierarchy has three levels of inputs, both observable and unobservable. Standards require the utilization of the highest possible level of input to determine fair value. Level 1 – inputs include quoted market prices in an active market for identical assets or liabilities. Level 2 – inputs are market data, other than Level 1, that are observable either directly or indirectly. Level 2 inputs include quoted market prices for similar assets or liabilities, quoted market prices in an inactive market, and other observable information that can be corroborated by market data. Level 3 – inputs are unobservable and corroborated by little or no market data. The carrying value and fair value, by fair value hierarchy, of the Company's financial instruments at March 31, 2022, and December 31, 2021, respectively, are as follows (in thousands): Fair Value Measurements at March 31, 2022 Fair Value at March 31, 2022 Quoted Prices in Significant Other Significant Recurring Marketable securities U.S. Treasury notes $ 199,106 $ 199,106 $ — $ — U.S. Government-sponsored enterprise securities 99,431 99,431 — — Other Liability-classified restricted stock awards 894 894 — — Total recurring $ 299,431 $ 299,431 $ — $ — Fair Value Measurements at December 31, 2021 Fair Value at December 31, 2021 Quoted Prices in Significant Other Significant Recurring Marketable securities U.S. Treasury notes $ 225,792 $ 225,792 $ — $ — U.S. Government-sponsored enterprise securities 113,944 113,944 — — Other Liability-classified restricted stock awards 702 702 — — Total recurring $ 340,438 $ 340,438 $ — $ — There were no transfers to or from Level 3 in the three months ended March 31, 2022. For the 2021 Bonds, the fair values are estimated using the Black-Derman-Toy interest rate lattice framework. The effective maturity of the 2021 Bonds was assumed to be April 1, 2024 (three years from issuance) with repayment of 100% of principal on that date. The impact of the Company's optional redemption feature, effective October 1, 2022, is appropriately captured by the Black-Derman-Toy interest rate lattice. The carrying values and estimated fair values of the 2021 bonds as of March 31, 2022, are summarized as follows: March 31, 2022 Carrying Value Estimated Fair Value 2021 Bonds $ 68,155 $ 66,657 The Company has not elected the fair value option for any of its instruments.

Segments

Segments	3 Months Ended
	Mar. 31, 2022
Segment Reporting [Abstract]
Segments	Segments The Company's chief operating decision maker is provided with and reviews a monthly executive package which separately identifies its business segments based on the nature of the products and services offered through each of its consolidated legal entities. In January 2021, the Company began to separately identify the Renewable Natural Gas Segment in the monthly executive package. As such, the Company has determined that it ha s three operati ng segments: (i) Gevo segment; (ii) Agri-Energy segment; (iii) Renewable Natural Gas seg ment. T ransactions between segments are eliminated in consolidation. Gevo segment . The Gevo segment is responsible for all research and development activities related to the future production of SAF, commercial opportunities for other renewable hydrocarbon products, such as hydrocarbons for gasoline blendstocks and diesel fuel; ingredients for the chemical industry, such as ethylene and butenes; plastics and materials; and other chemicals. The Gevo segment also develops, maintains and protects its intellectual property portfolio, provides corporate oversight services, and responsible for development and construction of our Net-Zero projects. Agri-Energy segment . The Agri-Energy segment is currently responsible for the operation of the Company’s Luverne Facility, development and optimization of the pro duction of isobutanol, ethanol and related products. Renewable natural gas segment . The Renewable Natural Gas segment produces low-carbon methane from manure for the production of RNG. Three Months Ended March 31, 2022 2021 Revenues: Gevo $ 63 $ 13 Agri-Energy 169 80 Renewable Natural Gas — — Consolidated $ 232 $ 93 Loss from operations: Gevo $ (12,124) $ (7,763) Agri-Energy (3,808) (2,047) Renewable Natural Gas (23) (68) Consolidated $ (15,955) $ (9,878) Acquisitions of patents, plant, property and equipment: Gevo $ 4,438 $ 253 Agri-Energy 3,947 10 Renewable Natural Gas 10,393 5,169 Consolidated $ 18,778 $ 5,432 March 31, 2022 December 31, 2021 Total assets Gevo $ 450,048 $ 484,528 Agri-Energy 65,834 64,008 Renewable Natural Gas 122,778 117,940 Consolidated (1) $ 638,660 $ 666,476

Subsequent Events

Subsequent Events	3 Months Ended
	Mar. 31, 2022
Subsequent Events [Abstract]
Subsequent Events	Subsequent Events In April 2022, Gevo signed an amendment to its Fuel Supply Agreement with Rock River Jerseys, LLC ("RRJ") to reimburse RRJ for part of the cost to install and operate covers for the lagoons at the RRJ dairy. This will allow Gevo to optimize efficiencies and could significantly improve the carbon intensity score at NW Iowa RNG. The Company's estimated share of the total capital cost for the improvements is approximately $1.9 million. The installatio n is expected to be completed early in the third quarter of 2022.

Nature of Business, Financial_2

Nature of Business, Financial Condition and Basis of Presentation (Policies)	3 Months Ended
	Mar. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of presentation	Basis of presentation. The unaudited consolidated financial statements of the Company (which include the accounts of its wholly-owned subsidiaries Gevo Asset, LLC, Gevo RNG HoldCo, LLC, Gevo NW Iowa RNG, LLC, Gevo Net-Zero HoldCo, LLC, Gevo Net-Zero 1 , LLC, and Agri-Energy, LLC (“Agri-Energy”)) have been prepared, without audit, pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”). Accordingly, they do not include all information and footnotes required by accounting principles generally accepted in the United States (“GAAP”) for complete financial statements. These statements reflect all normal and recurring adjustments which, in the opinion of management, are necessary to present fairly the financial position, results of operations and cash flows of the Company as of, and for the three months ended, March 31, 2022, and are not necessarily indicative of the results to be expected for the full year. These statements should be read in conjunction with the Company’s audited consolidated financial statements and notes thereto included under the heading “Financial Statements and Supplementary Data” in Part II, Item 8 of the Company’s Annual Report on Form 10-K for the year ended December 31, 2021 . The financial statements at December 31, 2021, have been derived from the audited financial statements as of that date. For further information, refer to our audited financial statements and notes thereto included for the year ended December 31, 2021 (the "2021 Annual Report").
Reclassifications	Reclassifications. The Company reclassified certain prior period amounts to conform to the current period presentation, including the categorization of depreciation and amortization on the Consolidated Statements of Operations. These reclassifications had no impact on total revenues, total cost of goods sold, total operating expenses, net loss or stockholders' equity for any period.

Net loss Per Share (Tables)

Net loss Per Share (Tables)	3 Months Ended
	Mar. 31, 2022
Earnings Per Share [Abstract]
Schedule of Net Loss Per Share	Basic and diluted net loss per share is calculated as follows (net loss in thousands): Three Months Ended March 31, 2022 2021 Net loss $ (15,673) $ (10,057) Basic and diluted weighted-average shares outstanding 201,925,747 183,566,524 Basic and diluted net loss per share $ (0.08) $ (0.05)

Prepaid and Other Current Ass_2

Prepaid and Other Current Assets (Tables)	3 Months Ended
	Mar. 31, 2022
Prepaid Expense and Other Assets, Current [Abstract]
Schedule of Prepaid and Other Assets	The following table sets forth the components of the Company’s prepaid and other current assets (in thousands): March 31, 2022 December 31, 2021 Prepaid insurance $ 397 $ 805 Interest receivable 1,252 1,530 Exclusivity fees — 3,250 Prepaid engineering 2,275 409 Prepaid other 1,937 863 Total Prepaid and other current assets $ 5,861 $ 6,857 The $3.3 million of prepaid fees above are exclusivity fees and are reported in Deposits and other assets in the Consolidated Balance Sheets (Note 13) as of March 31, 2022.

Marketable Securities (Tables)

Marketable Securities (Tables)	3 Months Ended
	Mar. 31, 2022
Investments, Debt and Equity Securities [Abstract]
Schedule of Investments in Marketable Securities	The Company's investments in marketable securities are stated at fair value and are available-for-sale. The following table summarizes the Company's investments in marketable securities (in thousands): Available-for-Sale Securities at Maturity Amortized Cost Basis Gross Unrealized Losses Fair Value Short-term marketable securities U.S. Treasury notes Within one year $ 188,665 $ (527) $ 188,138 U.S. Government-sponsored enterprise securities Within one year 78,375 (700) 77,675 Total short-term marketable securities $ 267,040 $ (1,227) $ 265,813 Long-term marketable securities U.S Treasury notes Within two years $ 11,040 $ (72) $ 10,968 U.S. Government-sponsored enterprise securities Within two years 22,044 (288) 21,756 Total long-term marketable securities $ 33,084 $ (360) $ 32,724 Available-for-Sale Securities at Maturity Amortized Cost Basis Gross Unrealized Losses Fair Value Short-term marketable securities U.S. Treasury notes Within one year $ 226,136 $ (344) $ 225,792 U.S. Government-sponsored enterprise securities Within one year 49,618 (70) 49,548 Total short-term marketable securities $ 275,754 $ (414) $ 275,340 Long-term marketable securities U.S Treasury notes Within two years $ — $ — $ — U.S. Government-sponsored enterprise securities Within two years 64,596 (200) 64,396 Total long-term marketable securities $ 64,596 $ (200) $ 64,396

Leases, Right-of-Use Assets a_2

Leases, Right-of-Use Assets and Related Liabilities (Tables)	3 Months Ended
	Mar. 31, 2022
Leases [Abstract]
Lease, Cost	The following table presents the (a) costs by lease category and (b) other quantitative information relating to the Company’s leases (in thousands): Three Months Ended March 31, 2022 2021 Lease Cost Finance lease cost: Amortization of right-of-use assets (1) $ 464 $ — Interest on lease liabilities (1) 262 11 Operating lease cost 139 61 Short-term lease cost 379 132 Variable lease cost (2) 115 39 Total lease cost $ 1,359 $ 243 (1) $0.6 million and $0.4 million of amortization and interest expense for the three months ended March 31, 2022 and 2021, respectively, were capitalized as part of construction in progress, for related finance lease liabilities of $23.0 million and $0.6 million, respectively. The accumulated capitalized amounts of $3.0 million are included in "Property, plant and equipment, net" in the Consolidated Balance Sheets as the related NW Iowa RNG facilities were still under construction on March 31, 2022. Since these leases include approximately 75% fuel supplies, when the RNG facilities reach 60% production (expected in the second or third quarter of 2022), these capitalized amounts will be moved to inventory, and as units are sold they will be expensed through cost of goods sold. (2) Represents amounts incurred in excess of minimum payments, including payments for common area expenses under our office and research facility lease, and additional amounts due under our NW Iowa RNG leases based on the number of cows maintained by the owners above the minimum required by the contracts of the respective facilities. Three Months Ended March 31, 2022 2021 Other Information Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from finance leases $ 16 $ 6 Operating cash flows from operating leases $ 456 $ 61 Finance cash flows from finance leases $ 34 $ 7 Right-of-use asset obtained in exchange for new finance lease liabilities $ — $ — Right-of-use asset obtained in exchange for new operating lease liabilities $ — $ 1,562 Weighted-average remaining lease term, finance lease (months) 215 221 Weighted-average remaining lease term, operating leases (months) 71 94 Weighted-average discount rate - finance leases (1) 5% 13% Weighted-average discount rate - operating leases (1) 5% 5% (1) The discount rate used for operating and finance leases is based on the Company's implicit borrowing rate ("IBR"). The Company estimated the IBR based on collateralized borrowings for similar terms and payments.
Operating Lease, Liability, Fiscal Year Maturity	The table below shows the future minimum payments under non-cancelable financing and operating leases at March 31, 2022 ( in thousands): Year ending December 31, Operating Leases Finance Leases 2022 (remaining) $ 447 $ 2,204 2023 528 1,713 2024 305 1,729 2025 315 1,743 2026 324 1,781 2027 and thereafter 706 22,130 Total 2,625 31,300 Less: Amounts representing present value discounts 371 9,868 Total lease liabilities 2,254 21,432 Less: current portion 416 4,029 Long-term portion $ 1,838 $ 17,403
Finance Lease, Liability, Fiscal Year Maturity	The table below shows the future minimum payments under non-cancelable financing and operating leases at March 31, 2022 ( in thousands): Year ending December 31, Operating Leases Finance Leases 2022 (remaining) $ 447 $ 2,204 2023 528 1,713 2024 305 1,729 2025 315 1,743 2026 324 1,781 2027 and thereafter 706 22,130 Total 2,625 31,300 Less: Amounts representing present value discounts 371 9,868 Total lease liabilities 2,254 21,432 Less: current portion 416 4,029 Long-term portion $ 1,838 $ 17,403

Inventories (Tables)

Inventories (Tables)	3 Months Ended
	Mar. 31, 2022
Inventory Disclosure [Abstract]
Schedule of Inventories	The following table sets forth the components of the Company’s inventory balances (in thousands): March 31, 2022 December 31, 2021 Raw materials Corn $ 223 $ 301 Enzymes and other inputs 108 183 Nutrients 2 3 Palladium 203 265 Finished goods SAF, Isooctane and Isooctene 501 335 Isobutanol 181 223 Ethanol 82 96 Work in process Agri-Energy 84 83 Gevo 51 — Spare parts 1,300 1,262 Total inventories $ 2,735 $ 2,751

Property, Plant, and Equipment

Property, Plant, and Equipment (Tables)	3 Months Ended
	Mar. 31, 2022
Property, Plant and Equipment [Abstract]
Schedule of Property, Plant and Equipment	The following table sets forth the Company’s property, plant and equipment by classification (in thousands): Useful Life (in years) March 31, 2022 December 31, 2021 Luverne Facility retrofit asset 20 $ 70,820 $ 70,820 Plant machinery and equipment 10 17,949 17,949 Site improvements 10 7,157 7,157 Lab equipment, furniture and fixtures and vehicles 5 6,813 6,811 Demonstration plant 2 3,597 3,597 Buildings 10 2,543 2,543 Leasehold improvements, pilot plant, land and support equipment 2 to 7 2,841 2,802 Computer, office equipment and software 3 to 6 2,338 2,332 Construction in progress — 107,848 88,989 Total property, plant and equipment 221,906 203,000 Less accumulated depreciation and amortization (65,010) (63,859) Property, plant and equipment, net $ 156,896 $ 139,141
Schedule Of Depreciation And Amortization Expense	The Company recorded depreciation and amortization expense related to property, plant and equipment and intangible assets as follows (in thousands): Three Months Ended March 31, 2022 2021 Depreciation: Cost of goods sold $ 1,086 $ 1,088 Operating expenses 65 56 Patent amortization: Cost of goods sold 5 5 Operating expenses 286 — Total depreciation and amortization $ 1,442 $ 1,149

Intangible Assets (Tables)

Intangible Assets (Tables)	3 Months Ended
	Mar. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Finite-Lived Intangible Assets	The following table sets forth the Company’s identifiable intangible assets by classification (in thousands): March 31, 2022 Gross Carrying Amount Accumulated Amortization Identifiable Intangible Assets, Net Weighted-Average Useful Life (Years) Finite-lived intangible assets: Patents $ 4,580 $ (516) $ 4,064 7.3 Defensive assets 4,900 (308) 4,592 8.4 Identifiable intangible assets $ 9,480 $ (824) $ 8,656 7.9 December 31, 2021 Gross Carrying Amount Accumulated Amortization Identifiable Intangible Assets, Net Weighted-Average Useful Life (Years) Finite-lived intangible assets: Patents $ 4,575 $ (368) $ 4,207 7.3 Defensive assets 4,895 (164) 4,731 8.4 Identifiable intangible assets $ 9,470 $ (532) $ 8,938 7.9
Schedule of Estimated Net Amortization of Identifiable Intangible Assets	The following table details the estimated amortization of identifiable intangible assets as of March 31, 2022 ( in thousands): Year ending December 31, Patents Defensive Assets Total 2022 (remaining) $ 452 $ 442 $ 894 2023 599 586 1,185 2024 601 588 1,189 2025 599 586 1,185 2026 585 586 1,171 2027 and thereafter 1,228 1,804 3,032 Total $ 4,064 $ 4,592 $ 8,656

Warrants (Tables)

Warrants (Tables)	3 Months Ended
	Mar. 31, 2022
Equity [Abstract]
Schedule of Warrants	The following table sets forth information pertaining to shares issued upon the exercise of warrants: Issuance Date Expiration Date Exercise Price as of March 31, 2022 Shares Underlying Warrants on Issuance Date Shares Issued upon Warrant Exercises as of March 31, 2022 Shares Underlying Warrants Outstanding as of March 31, 2022 Series 2020-A Warrants (1) 7/6/2020 7/6/2025 $ 0.60 30,000,000 29,914,069 85,931 (1) The Series 2020-A Warrants are equity-classified warrants. During the three months ended March 31, 2022 , common stock was issued as a result of the exercise of warrants as shown below (dollars in thousands): Common Stock Issued Proceeds Series 2020-A Warrants 4,677 $ 3

Accounts Payable and Accrued _2

Accounts Payable and Accrued Liabilities (Tables)	3 Months Ended
	Mar. 31, 2022
Payables and Accruals [Abstract]
Schedule of Accounts Payable and Accrued Liabilities	The following table sets forth the components of the Company's accounts payable and accrued liabilities (in thousands): March 31, 2022 December 31, 2021 Accounts payable - trade $ 1,399 $ 4,868 NW Iowa RNG accrued project costs 2,902 11,000 Accrued employee compensation 3,294 4,678 Net-Zero 1 accrued project costs 2,778 5,010 Other accrued liabilities 3,037 2,732 Total accounts payable and accrued liabilities $ 13,410 $ 28,288

Debt (Tables)

Debt (Tables)	3 Months Ended
	Mar. 31, 2022
Debt Disclosure [Abstract]
Schedule of Restrictions on Cash Held Bond Trustee	The restricted cash held by the Trustee is made up of the following (in thousands). Numbers are stated since inception and as of March 31, 2022: March 31, 2022 Bond proceeds $ 68,995 Disbursement of funds (53,085) Interest paid on bonds (727) Interest income 11 Total restricted cash held by Trustee 15,194 Total restricted cash for collateral 71,260 Total restricted cash and restricted cash equivalents 86,454 Current portion (16,216) Total restricted cash held by Trustee $ 70,238
Schedule of 2021 Bonds and Loans Payable - Other	The summary of the 2021 Bonds and Loans payable - other are as follows (in thousands): Interest Rate Maturity Date March 31, 2022 December 31, 2021 2021 Bonds 1.5% January 2042 $ 66,669 $ 66,486 SBA Loans 1.0% April 2025 296 320 Equipment 4% to 5% February 2022 to December 2024 70 156 Total loans payable - other 67,035 66,962 Less current portion (89) (158) Long-term portion $ 66,946 $ 66,804
Schedule of Future Principal Payments for Long-term Debt	Future principal payments for the Company's long-term debt are as follows (in thousands): Year Ending December 31, 2022 (remaining) $ 48 2023 159 2024 66,799 2025 29 2026 — $ 67,035

Deposits and Other Assets (Tabl

Deposits and Other Assets (Tables)	3 Months Ended
	Mar. 31, 2022
Other Assets, Noncurrent [Abstract]
Deposits and Other Assets	Deposits and other assets include the following: March 31, 2022 December 31, 2021 Deposits (1) $ 881 $ 831 Investment in Juhl (2) 1,500 1,500 Exclusivity fees (3) 3,250 — Total Deposits and Other Assets $ 5,631 $ 2,331 (1) Deposits for legal services and for product for Net-Zero 1. (2) Investment in Juhl's future wind farms.

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	3 Months Ended
	Mar. 31, 2022
Equity [Abstract]
Schedule of Restricted Common Stock And Non-qualified Stock Option Activity	Restricted common stock and non-qualified stock option activity during the three months ended March 31, 2022, consisted of the following: Period Total Number of Restricted Shares Issued Total Number of Non-qualified Stock Options Granted Vesting Periods Years January 1, 2022 to March 31, 2022 (340,502) (1) — N/A Total (340,502) —
Schedule of Stock-based Compensation Expense	The following table sets forth the Company’s stock-based compensation expense for the periods indicated (in thousands): Three Months Ended March 31, 2022 2021 Equity Classified Awards Stock options Cost of goods sold $ 85 $ — Research and development 51 — Selling, general and administrative 1,444 — Preliminary stage projects 5 Other 94 Restricted stock Cost of goods sold 108 — Research and development 58 125 Selling, general and administrative 2,050 437 Preliminary stage projects 11 Other 138 Total equity classified awards 4,044 562 Liability Classified Awards Restricted stock Selling, general and administrative 193 — Stock appreciation rights Research and development — 348 Selling, general and administrative 21 15 Total liability classified awards 214 363 Total stock-based compensation $ 4,258 $ 925
Schedule Stock Option Award Activity	Stock option activity under the Company’s stock incentive plans and changes during the three months ended March 31, 2022, were as follows: Number of Options Weighted-Average Exercise Price (1) Weighted-Average Remaining Contractual Term (years) Aggregate Intrinsic Value Options outstanding at December 31, 2021 4,739,940 $ 5.14 9.6 $ — Granted — Canceled or forfeited (174,187) $ 5.63 Exercised — Options outstanding at March 31, 2022 4,565,753 $ 5.12 9.4 $ — Options exercisable at March 31, 2022 1,520 $ 427.69 4.4 $ — (1) Exercise price of options outstanding range from $4 to $99,300 as of March 31, 2022 . The higher range is related to historical stock reverse splits.
Schedule of Non-vested Restricted Stock Awards	Non-vested restricted stock awards and the changes during the three months ended March 31, 2022, were as follows: Number of Shares Weighted-Average Grant-Date Fair Value Outstanding at December 31, 2021 7,094,785 $ 3.93 Granted — $ — Exercised (165,870) $ 1.09 Canceled or forfeited (174,268) $ 4.53 Vested (364) $ 2.30 Non-vested at March 31, 2022 6,754,283 $ 4.01

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	3 Months Ended
	Mar. 31, 2022
Fair Value Disclosures [Abstract]
Fair Value Measurements, Recurring and Nonrecurring	The carrying value and fair value, by fair value hierarchy, of the Company's financial instruments at March 31, 2022, and December 31, 2021, respectively, are as follows (in thousands): Fair Value Measurements at March 31, 2022 Fair Value at March 31, 2022 Quoted Prices in Significant Other Significant Recurring Marketable securities U.S. Treasury notes $ 199,106 $ 199,106 $ — $ — U.S. Government-sponsored enterprise securities 99,431 99,431 — — Other Liability-classified restricted stock awards 894 894 — — Total recurring $ 299,431 $ 299,431 $ — $ — Fair Value Measurements at December 31, 2021 Fair Value at December 31, 2021 Quoted Prices in Significant Other Significant Recurring Marketable securities U.S. Treasury notes $ 225,792 $ 225,792 $ — $ — U.S. Government-sponsored enterprise securities 113,944 113,944 — — Other Liability-classified restricted stock awards 702 702 — — Total recurring $ 340,438 $ 340,438 $ — $ —
Schedule of Carrying Values and Estimated Fair Values of Debt Instruments	The carrying values and estimated fair values of the 2021 bonds as of March 31, 2022, are summarized as follows: March 31, 2022 Carrying Value Estimated Fair Value 2021 Bonds $ 68,155 $ 66,657

Segments (Tables)

Segments (Tables)	3 Months Ended
	Mar. 31, 2022
Segment Reporting [Abstract]
Schedule of Segment Reporting Information, by Segment	Three Months Ended March 31, 2022 2021 Revenues: Gevo $ 63 $ 13 Agri-Energy 169 80 Renewable Natural Gas — — Consolidated $ 232 $ 93 Loss from operations: Gevo $ (12,124) $ (7,763) Agri-Energy (3,808) (2,047) Renewable Natural Gas (23) (68) Consolidated $ (15,955) $ (9,878) Acquisitions of patents, plant, property and equipment: Gevo $ 4,438 $ 253 Agri-Energy 3,947 10 Renewable Natural Gas 10,393 5,169 Consolidated $ 18,778 $ 5,432 March 31, 2022 December 31, 2021 Total assets Gevo $ 450,048 $ 484,528 Agri-Energy 65,834 64,008 Renewable Natural Gas 122,778 117,940 Consolidated (1) $ 638,660 $ 666,476

Nature of Business, Financial_3

Nature of Business, Financial Condition and Basis of Presentation (Details) milking_cow in Thousands, ft² in Thousands, MMBTU in Thousands	Mar. 31, 2022aft²MMBTUmilking_cowdairy
Nature of Business, Financial Condition and Basis of Presentation [Line Items]
Number of milking cows | milking_cow	20
Number of dairies | dairy	3
Digester production capacity (In MMBtu) | MMBTU	355
Land | Luverne, Minnesota
Nature of Business, Financial Condition and Basis of Presentation [Line Items]
Area of land | a	55
Building and Building Improvements | Luverne, Minnesota
Nature of Business, Financial Condition and Basis of Presentation [Line Items]
Area of real estate property | ft²	50

Revenues from Contracts with _2

Revenues from Contracts with Customers and Other Revenues - Narrative (Details)	3 Months Ended
	Mar. 31, 2022USD ($)plant	Mar. 31, 2021USD ($)	Dec. 31, 2021USD ($)
Revenue from Contract with Customer [Abstract]
Number of operating plants | plant	2
Variable revenues	$ 0	$ 0
Revenue, remaining performance obligation, amount	$ 0		$ 0
Revenue and trade receivables recorded as percentage of transaction price	100.00%

Net loss Per Share - Narrative

Net loss Per Share - Narrative (Details) - shares	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Earnings Per Share [Abstract]
Potential anti-dilutive shares were excluded from earnings per share calculation	1,751,170	220,099

Net loss Per Share - Basic and

Net loss Per Share - Basic and Diluted Net Loss per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Earnings Per Share [Abstract]
Net loss	$ (15,673)	$ (10,057)
Net loss	$ (15,673)	$ (10,057)
Basic weighted-average shares outstanding (in shares)	201,925,747	183,566,524
Diluted weighted-average shares outstanding (in shares)	201,925,747	183,566,524
Basic loss per share (in dollars per share)	$ (0.08)	$ (0.05)
Diluted loss per share (in dollars per share)	$ (0.08)	$ (0.05)

Prepaid and Other Current Ass_3

Prepaid and Other Current Assets (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Prepaid Expense and Other Assets, Current [Abstract]
Prepaid insurance	$ 397	$ 805
Interest receivable	1,252	1,530
Exclusivity fees	0	3,250
Prepaid engineering	2,275	409
Prepaid other	1,937	863
Prepaid expenses and other current assets	5,861	$ 6,857
Prepaid fees	$ 3,300

Marketable Securities - Investm

Marketable Securities - Investments In Marketable Securities (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Debt Securities, Available-for-sale [Line Items]
Short-term marketable securities, amortized cost basis	$ 267,040	$ 275,754
Short-term marketable securities, gross unrealized losses	(1,227)	(414)
Short-term marketable securities, fair value	265,813	275,340
Long-term marketable securities, amortized cost basis	33,084	64,596
Long-term marketable securities, gross unrealized losses	(360)	(200)
Long-term marketable securities, fair value	32,724	64,396
U.S. Treasury notes
Debt Securities, Available-for-sale [Line Items]
Short-term marketable securities, amortized cost basis	188,665	226,136
Short-term marketable securities, gross unrealized losses	(527)	(344)
Short-term marketable securities, fair value	188,138	225,792
Long-term marketable securities, amortized cost basis	11,040	0
Long-term marketable securities, gross unrealized losses	(72)	0
Long-term marketable securities, fair value	10,968	0
U.S. Government-sponsored enterprise securities
Debt Securities, Available-for-sale [Line Items]
Short-term marketable securities, amortized cost basis	78,375	49,618
Short-term marketable securities, gross unrealized losses	(700)	(70)
Short-term marketable securities, fair value	77,675	49,548
Long-term marketable securities, amortized cost basis	22,044	64,596
Long-term marketable securities, gross unrealized losses	(288)	(200)
Long-term marketable securities, fair value	$ 21,756	$ 64,396

Marketable Securities - Narrati

Marketable Securities - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
Marketable Securities [Line Items]
Interest receivable	$ 1,252		$ 1,530
Interest income	1,600	$ 0
Marketable securities maturities in 2022	207,000
Marketable securities maturities in 2023	91,500
Prepaid Expenses and Other Current Assets
Marketable Securities [Line Items]
Interest receivable	$ 1,300

Leases, Right-of-Use Assets a_3

Leases, Right-of-Use Assets and Related Liabilities - Narrative (Details) $ in Thousands	Mar. 31, 2022USD ($)contractsite	Dec. 31, 2021USD ($)
Leases [Abstract]
Operating right-of-use assets	$ 2,209	$ 2,414
Total lease liabilities	2,254
Operating lease liabilities (current)	416	772
Operating lease liabilities (long-term)	$ 1,838	1,902
Number of finance lease | contract	4
Number of digester sites | site	3
Finance right-of-use assets	$ 26,887	27,297
Total lease liabilities	21,432
Finance lease liabilities (current)	4,029	3,413
Finance lease liabilities (long-term)	$ 17,403	$ 17,797

Leases, Right-of-Use Assets a_4

Leases, Right-of-Use Assets and Related Liabilities - Lease Cost (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
Lease Cost
Amortization of right-of-use assets	$ 464	$ 0
Interest on lease liabilities	262	11
Operating lease cost	139	61
Short-term lease cost	379	132
Variable lease cost	115	39
Total lease cost	1,359	243
Finance right-of-use assets	$ 26,887		$ 27,297
Finance lease, percentage of fuel supplies to move capitalized amount to inventory	60.00%
Construction in progress
Lease Cost
Amortization of right-of-use assets	$ 600	400
Interest on lease liabilities	23,000	$ 600
Finance right-of-use assets	$ 3,000
Finance lease, percentage of fuel supplies	75.00%

Leases, Right-of-Use Assets a_5

Leases, Right-of-Use Assets and Related Liabilities - Other Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from finance leases	$ 16	$ 6
Operating cash flows from operating leases	456	61
Finance cash flows from finance leases	34	7
Right-of-use asset obtained in exchange for new finance lease liabilities	0	0
Right-of-use asset obtained in exchange for new operating lease liabilities	$ 0	$ 1,562
Weighted-average remaining lease term, finance lease (months)	215 months	221 months
Weighted-average remaining lease term, operating leases (months)	71 months	94 months
Weighted-average discount rate - finance leases	5.00%	13.00%
Weighted-average discount rate - operating leases	5.00%	5.00%

Leases, Right-of-Use Assets a_6

Leases, Right-of-Use Assets and Related Liabilities - Future Minimum Payments Under Non-Cancelable (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Operating Leases
2022 (remaining)	$ 447
2023	528
2024	305
2025	315
2026	324
2027 and thereafter	706
Total	2,625
Less: Amounts representing present value discounts	371
Total lease liabilities	2,254
Less: current portion	416	$ 772
Long-term portion	1,838	1,902
Finance Leases
2022 (remaining)	2,204
2023	1,713
2024	1,729
2025	1,743
2026	1,781
2027 and thereafter	22,130
Total	31,300
Less: Amounts representing present value discounts	9,868
Total lease liabilities	21,432
Less: current portion	4,029	3,413
Long-term portion	$ 17,403	$ 17,797

Inventories - Components of Inv

Inventories - Components of Inventory Balances (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Inventory [Line Items]
Spare parts	$ 1,300	$ 1,262
Inventories	2,735	2,751
Corn
Inventory [Line Items]
Raw materials	223	301
Enzymes and other inputs
Inventory [Line Items]
Raw materials	108	183
Nutrients
Inventory [Line Items]
Raw materials	2	3
Palladium
Inventory [Line Items]
Raw materials	203	265
SAF, Isooctane and Isooctene
Inventory [Line Items]
Finished goods	501	335
Isobutanol
Inventory [Line Items]
Finished goods	181	223
Ethanol
Inventory [Line Items]
Finished goods	82	96
Agri-Energy
Inventory [Line Items]
Work in process	84	83
Gevo
Inventory [Line Items]
Work in process	$ 51	$ 0

Inventories - Narrative (Detail

Inventories - Narrative (Details) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Inventory Disclosure [Abstract]
Inventory write-down	$ 2,900,000	$ 0

Property, Plant, and Equipmen_2

Property, Plant, and Equipment - Property, Plant and Equipment by Classification (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 221,906	$ 203,000
Less accumulated depreciation and amortization	(65,010)	(63,859)
Property, plant and equipment, net	$ 156,896	139,141
Luverne Facility retrofit asset
Property, Plant and Equipment [Line Items]
Useful Life (in years)	20 years
Property, plant and equipment, gross	$ 70,820	70,820
Plant machinery and equipment
Property, Plant and Equipment [Line Items]
Useful Life (in years)	10 years
Property, plant and equipment, gross	$ 17,949	17,949
Site improvements
Property, Plant and Equipment [Line Items]
Useful Life (in years)	10 years
Property, plant and equipment, gross	$ 7,157	7,157
Lab equipment, furniture and fixtures and vehicles
Property, Plant and Equipment [Line Items]
Useful Life (in years)	5 years
Property, plant and equipment, gross	$ 6,813	6,811
Demonstration plant
Property, Plant and Equipment [Line Items]
Useful Life (in years)	2 years
Property, plant and equipment, gross	$ 3,597	3,597
Buildings
Property, Plant and Equipment [Line Items]
Useful Life (in years)	10 years
Property, plant and equipment, gross	$ 2,543	2,543
Leasehold improvements, pilot plant, land and support equipment
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 2,841	2,802
Leasehold improvements, pilot plant, land and support equipment | Minimum
Property, Plant and Equipment [Line Items]
Useful Life (in years)	2 years
Leasehold improvements, pilot plant, land and support equipment | Maximum
Property, Plant and Equipment [Line Items]
Useful Life (in years)	7 years
Computer, office equipment and software
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 2,338	2,332
Computer, office equipment and software | Minimum
Property, Plant and Equipment [Line Items]
Useful Life (in years)	3 years
Computer, office equipment and software | Maximum
Property, Plant and Equipment [Line Items]
Useful Life (in years)	6 years
Construction in progress
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 107,848	$ 88,989

Property, Plant, and Equipmen_3

Property, Plant, and Equipment - Depreciation and Amortization Expense (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Property, Plant and Equipment [Line Items]
Total depreciation and amortization	$ 1,442	$ 1,149
Cost of goods sold
Property, Plant and Equipment [Line Items]
Depreciation:	1,086	1,088
Amortization of intangible assets (less than)	5	5
Operating expenses
Property, Plant and Equipment [Line Items]
Depreciation:	65	56
Amortization of intangible assets (less than)	$ 286	$ 0

Property, Plant, and Equipmen_4

Property, Plant, and Equipment - Narrative (Details) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 221,906,000		$ 203,000,000
Interest expense capitalized	500,000	$ 0
Construction in progress
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	107,848,000		88,989,000
Construction in progress | Gevo
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	600,000		400,000
Construction in progress | Agri-Energy
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	13,100,000		9,100,000
Construction in progress | NW Lowa RNG
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	67,400,000		56,900,000
Construction in progress | Net Zero Segment
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 26,800,000		$ 22,500,000

Intangible Assets - Identifiabl

Intangible Assets - Identifiable Intangible Assets (Details) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 9,480	$ 9,470
Accumulated Amortization	(824)	(532)
Identifiable Intangible Assets, Net	$ 8,656	$ 8,938
Weighted-Average Useful Life (Years)	7 years 10 months 24 days	7 years 10 months 24 days
Patents
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 4,580	$ 4,575
Accumulated Amortization	(516)	(368)
Identifiable Intangible Assets, Net	$ 4,064	$ 4,207
Weighted-Average Useful Life (Years)	7 years 3 months 18 days	7 years 3 months 18 days
Defensive assets
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 4,900	$ 4,895
Accumulated Amortization	(308)	(164)
Identifiable Intangible Assets, Net	$ 4,592	$ 4,731
Weighted-Average Useful Life (Years)	8 years 4 months 24 days	8 years 4 months 24 days

Intangible Assets - Estimated A

Intangible Assets - Estimated Amortization of Identifiable Intangible Assets (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
2022 (remaining)	$ 894
2023	1,185
2024	1,189
2025	1,185
2026	1,171
2027 and thereafter	3,032
Identifiable Intangible Assets, Net	8,656	$ 8,938
Patents
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
2022 (remaining)	452
2023	599
2024	601
2025	599
2026	585
2027 and thereafter	1,228
Identifiable Intangible Assets, Net	4,064	4,207
Defensive assets
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
2022 (remaining)	442
2023	586
2024	588
2025	586
2026	586
2027 and thereafter	1,804
Identifiable Intangible Assets, Net	$ 4,592	$ 4,731

Warrants - Narrative (Details)

Warrants - Narrative (Details)	Feb. 17, 2022shares
Series K Warrants
Class of Warrant or Right [Line Items]
Unexercised Price (in dollars per share)	7,126

Warrants - Shares Issued Upon E

Warrants - Shares Issued Upon Exercise of Warrants (Details) - Series 2020-A Warrants	Mar. 31, 2022$ / sharesshares
Class of Warrant or Right [Line Items]
Exercise Price (in dollars per share) | $ / shares	$ 0.60
Shares Underlying Warrants Issuance (in shares)	30,000,000,000
Shares Issued upon Warrant Exercises (in shares)	29,914,069,000
Shares Underlying Warrants Outstanding (in shares)	85,931,000

Warrants - Exercise of Warrants

Warrants - Exercise of Warrants (Details) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Class of Warrant or Right [Line Items]
Proceeds from exercise of warrants	$ 3	$ 1,117
Series 2020-A Warrants
Class of Warrant or Right [Line Items]
Common stock Issued upon exercise of warrants (in shares)	4,677
Proceeds from exercise of warrants	$ 3

Accounts Payable and Accrued _3

Accounts Payable and Accrued Liabilities (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Accounts Payable and Accrued Liabilities [Line Items]
Accounts payable - trade	$ 1,399	$ 4,868
Accrued employee compensation	3,294	4,678
Other accrued liabilities	3,037	2,732
Total accounts payable and accrued liabilities	13,410	28,288
NW Lowa RNG
Accounts Payable and Accrued Liabilities [Line Items]
Accrued project costs	2,902	11,000
Net Zero Segment
Accounts Payable and Accrued Liabilities [Line Items]
Accrued project costs	$ 2,778	$ 5,010

Debt - Narrative (Details)

Debt - Narrative (Details) - USD ($)	Apr. 15, 2021	Apr. 30, 2020	Mar. 31, 2022	Dec. 31, 2021
Debt Instrument [Line Items]
Debt collateral amount	$ 71,200,000
Long-term debt			$ 67,035,000	$ 66,962,000
2021 Bonds
Debt Instrument [Line Items]
Aggregate principal amount	$ 68,155,000
Interest Rate	1.50%
Debt collateral amount	$ 71,200,000
Debt premium	800,000		600,000
Debt issuance costs	3,000,000		2,100,000
Used bond proceeds			53,000,000
Unused bond proceeds			$ 15,200,000
2021 Bonds | Letter of Credit
Debt Instrument [Line Items]
Cash deposited in bank	$ 71,200,000
2021 Bonds | Loans Payable
Debt Instrument [Line Items]
Interest Rate			1.50%
Long-term debt			$ 66,669,000	66,486,000
SBA Loans | Loans Payable
Debt Instrument [Line Items]
Interest Rate	1.00%		1.00%
Proceeds from issuance of long-term debt		$ 1,000,000
Debt instrument, decrease, forgiveness	$ 500,000
Long-term debt	300,000		$ 296,000	$ 320,000
Debt Instrument, monthly payment	8,230
SBA Loans | Loans Payable | Agri-Energy
Debt Instrument [Line Items]
Debt instrument, decrease, forgiveness	$ 100,000

Debt - Restricted Cash Held by

Debt - Restricted Cash Held by Bond Trustee (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021	Mar. 31, 2021
Restricted Cash and Cash Equivalents [Abstract]
Bond proceeds	$ 68,995
Disbursement of funds	(53,085)
Interest paid on bonds	(727)
Interest income	11
Total restricted cash held by Trustee	15,194
Total restricted cash for collateral	71,260
Total restricted cash and restricted cash equivalents	86,454
Current portion	(16,216)	$ (25,032)	$ 0
Long-term restricted cash	$ 70,238	$ 70,168	$ 0

Debt - 2021 Bonds and Loans Pay

Debt - 2021 Bonds and Loans Payable - Other (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021	Apr. 15, 2021
Debt Instrument [Line Items]
Long-term debt, total	$ 67,035	$ 66,962
Less current portion	(89)	(158)
Long-term portion	$ 66,946	66,804
2021 Bonds
Debt Instrument [Line Items]
Interest Rate			1.50%
Loans Payable | 2021 Bonds
Debt Instrument [Line Items]
Interest Rate	1.50%
Long-term debt, total	$ 66,669	66,486
Loans Payable | SBA Loans
Debt Instrument [Line Items]
Interest Rate	1.00%		1.00%
Long-term debt, total	$ 296	320	$ 300
Loans Payable | Equipment
Debt Instrument [Line Items]
Long-term debt, total	$ 70	$ 156
Loans Payable | Equipment | Minimum
Debt Instrument [Line Items]
Interest Rate	4.00%
Loans Payable | Equipment | Maximum
Debt Instrument [Line Items]
Interest Rate	5.00%

Debt - Future Principal Payment

Debt - Future Principal Payments for Long-term Debt (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Debt Disclosure [Abstract]
2022 (remaining)	$ 48
2023	159
2024	66,799
2025	29
2026	0
Long-term debt, total	$ 67,035	$ 66,962

Deposits and Other Assets (Deta

Deposits and Other Assets (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Other Assets, Noncurrent [Abstract]
Deposits	$ 881	$ 831
Investment in Juhl	1,500	1,500
Exclusivity fees (3)	3,250	0
Deposits and other assets	$ 5,631	$ 2,331

Stock-Based Compensation - Narr

Stock-Based Compensation - Narrative (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Jun. 09, 2021
Schedule of Equity Incentive Plans [Line Items]
Purchases of common stock under ESPP (in shares)	0	0
Options, vested, number of shares (in shares)	0
Stock option
Schedule of Equity Incentive Plans [Line Items]
Total unrecognized compensation expense, net of estimated forfeitures, relating to stock options	$ 16.6
Share-based payment arrangement, nonvested award, cost not yet recognized, period for recognition (year)	3 years 7 months 6 days
Restricted stock
Schedule of Equity Incentive Plans [Line Items]
Share-based payment arrangement, nonvested award, cost not yet recognized, period for recognition (year)	2 years 10 months 24 days
Total unrecognized compensation expense, net of estimated forfeitures, relating to restricted stock awards	$ 19.4
Deferred compensation share-based arrangements, liability	$ 1
2010 Plan
Schedule of Equity Incentive Plans [Line Items]
Number of shares of common stock reserved for issuance (in shares)			22,980,074
Number of shares available (in shares)	7,717,026
Employee Stock Purchase Plan
Schedule of Equity Incentive Plans [Line Items]
Number of shares of common stock reserved for issuance (in shares)	190,000
Number of shares available (in shares)	190,000
Purchase price of common stock, percent	85.00%

Stock-Based Compensation - Rest

Stock-Based Compensation - Restricted Common Stock and Non-qualified Stock Option Activity (Details) - shares	3 Months Ended	134 Months Ended
	Mar. 31, 2022	Mar. 31, 2022
Restricted stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total Number of Restricted Shares Issued (in shares)	(340,502,000)	(340,502,000)
Non-qualified Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total Number of Non-qualified Stock Options Granted (in shares)	0	0

Stock-based Compensation - Stoc

Stock-based Compensation - Stock-based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation	$ 4,258	$ 925
Research and development
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation	100	500
Selling, general and administrative
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation	1,400	500
Other
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation	100	0
Stock option | Cost of goods sold
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation	85	0
Stock option | Research and development
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation	51	0
Stock option | Selling, general and administrative
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation	1,444	0
Stock option | Preliminary stage projects
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation	5
Stock option | Other
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation	94
Restricted stock | Cost of goods sold
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation	108	0
Restricted stock | Research and development
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation	58	125
Restricted stock | Selling, general and administrative
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation	2,050	437
Restricted stock | Preliminary stage projects
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation	11
Restricted stock | Other
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation	138
Equity Classified Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation	4,044	562
Restricted stock | Selling, general and administrative
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation	193	0
Stock appreciation rights | Research and development
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation	0	348
Stock appreciation rights | Selling, general and administrative
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation	21	15
Liability Classified Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation	$ 214	$ 363

Stock-based Compensation - St_2

Stock-based Compensation - Stock Option Award Activity (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Outstanding, Beginning Balance (in shares)	4,739,940,000
Granted (in shares)	0
Canceled or forfeited (in shares)	(174,187,000)
Exercised (in shares)	0
Outstanding, Ending Balance (in shares)	4,565,753,000	4,739,940,000
Options exercisable (in shares)	1,520,000
Weighted-Average Exercise Price
Beginning Balance (in dollars per share)	$ 5,140
Granted (in dollars per share)
Canceled or forfeited (in dollars per share)	5.63
Exercised (in dollars per share)
Ending Balance (in dollars per share)	5.12	$ 5,140
Options exercisable (in dollars per share)	$ 427.69
Weighted-Average Remaining Contractual Term (years) And Aggregate Intrinsic Value
Options Outstanding, Weighted Average Remaining Contractual Term (years)	9 years 4 months 24 days	9 years 7 months 6 days
Options Exercisable, Weighted Average Remaining Contractual Term (years)	4 years 4 months 24 days
Options Outstanding, Aggregate Intrinsic Value	$ 0	$ 0
Options Exercisable, Aggregate Intrinsic Value	$ 0
Minimum
Weighted-Average Remaining Contractual Term (years) And Aggregate Intrinsic Value
Exercise price of options outstanding (in dollars per share)	$ 4
Maximum
Weighted-Average Remaining Contractual Term (years) And Aggregate Intrinsic Value
Exercise price of options outstanding (in dollars per share)	$ 99,300

Stock-based Compensation - Non-

Stock-based Compensation - Non-vested Restricted Stock (Details) - Restricted stock	3 Months Ended
	Mar. 31, 2022$ / sharesshares
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Outstanding , Beginning Balance (in shares) | shares	7,094,785,000
Granted (in shares) | shares	0
Exercised (in shares) | shares	(165,870,000)
Canceled or forfeited (in shares) | shares	(174,268,000)
Vested (in shares) | shares	(364,000)
Nonvested, Ending Balance (in shares) | shares	6,754,283,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Outstanding , Beginning Balance (in dollars per share) | $ / shares	$ 3.93
Granted (in dollars per share) | $ / shares	0
Exercised (in dollars per share) | $ / shares	1.09
Canceled or forfeited (in dollars per share) | $ / shares	4.53
Vested (in dollars per share) | $ / shares	2.30
Nonvested, Ending Balance (in dollars per share) | $ / shares	$ 4.01

Commitments and Contingencies (

Commitments and Contingencies (Details)	Mar. 31, 2022USD ($)
Commitments and Contingencies Disclosure [Abstract]
Liabilities associated with indemnities	$ 0
Environmental liabilities	$ 0

Fair Value Measurements - Fair

Fair Value Measurements - Fair Value Measurements, Recurring and Nonrecurring (Details) - Recurring - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Liability-classified restricted stock awards	$ 894	$ 702
Total recurring	299,431	340,438
Quoted Prices in Active Markets for Identical Assets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Liability-classified restricted stock awards	894	702
Total recurring	299,431	340,438
Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Liability-classified restricted stock awards	0	0
Total recurring	0	0
Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Liability-classified restricted stock awards	0	0
Total recurring	0	0
U.S. Treasury notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	199,106	225,792
U.S. Treasury notes | Quoted Prices in Active Markets for Identical Assets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	199,106	225,792
U.S. Treasury notes | Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	0	0
U.S. Treasury notes | Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	0	0
U.S. Government-sponsored enterprise securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	99,431	113,944
U.S. Government-sponsored enterprise securities | Quoted Prices in Active Markets for Identical Assets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	99,431	113,944
U.S. Government-sponsored enterprise securities | Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	0	0
U.S. Government-sponsored enterprise securities | Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	$ 0	$ 0

Fair Value Measurements - Carry

Fair Value Measurements - Carrying Values and Estimated Fair Values (Details) - 2021 Bonds $ in Thousands	Mar. 31, 2022USD ($)
Carrying Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Debt instrument, fair value disclosure	$ 68,155
Estimated Fair Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Debt instrument, fair value disclosure	$ 66,657

Segments- Narrative (Details)

Segments- Narrative (Details)	3 Months Ended
	Mar. 31, 2022segment
Segment Reporting [Abstract]
Number of operating segments	3

Segments - Segment Reporting In

Segments - Segment Reporting Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
Segment Reporting Information [Line Items]
Revenues	$ 232	$ 93
Loss from operations	(15,955)	(9,878)
Acquisitions of property, plant and equipment	18,778	5,432
Total assets	638,660		$ 666,476
Operating Segments | Gevo
Segment Reporting Information [Line Items]
Revenues	63	13
Loss from operations	(12,124)	(7,763)
Acquisitions of property, plant and equipment	4,438	253
Total assets	450,048		484,528
Operating Segments | Agri-Energy
Segment Reporting Information [Line Items]
Revenues	169	80
Loss from operations	(3,808)	(2,047)
Acquisitions of property, plant and equipment	3,947	10
Total assets	65,834		64,008
Operating Segments | Renewable Natural Gas
Segment Reporting Information [Line Items]
Revenues	0	0
Loss from operations	(23)	(68)
Acquisitions of property, plant and equipment	10,393	$ 5,169
Total assets	$ 122,778		$ 117,940

Subsequent Events (Details)

Subsequent Events (Details) $ in Millions	1 Months Ended
	Apr. 30, 2022USD ($)
Gevo | Subsequent Event
Subsequent Event [Line Items]
Capital cost for improvements	$ 1.9